ClinicalTrials.gg
Sign In

Biological

Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells clinical trials

studies test it
4
open now
2
in phase 3
0
first study started
2010

Keep track of what changes. Save the Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

TTRNA-xALT
3

Studies by the year they started

4 studies that test it; most in 2010 (1)

Studies that test Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells, by start year
YearStudies
20101
20211
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
1

What it is tested for

Each study’s main condition, where its own words name it.

Medulloblastoma
2
Neuroblastoma
1
Oligodendroglioma
1

Who runs them

Industry 0 · Other 4

University of Florida (4)

Often tested with

Tested in the same studies.

Diphtheria-Tetanus Vaccine (2) · Pembrolizumab (1)

Studies

Open first, then newest update. How each study uses Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 2 — Total Tumor mRNA-pulsed Tumor-specific Ex vivo-expanded Autologous Lymphocyte Transfer Cells is usual care beside what is tested